Effect of Intravitreous Anti–Vascular Endothelial Growth Factor Therapy on Choroidal Thickness in Neovascular Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography
- Branchini, Lauren
- Regatieri, Caio
- Adhi, Mehreen
- Flores-Moreno, Ignacio
- Manjunath, Varsha
- Fujimoto, James G.
- Duker, Jay S.
Publication date
March 2013
DOI Publisher
American Medical Association (AMA) ISSN
2168-6165 Journal
JAMA Ophthalmology Citation count (estimate)
25Abstract
A critical method of monitoring patients with neovascular age-related macular degeneration (AMD) being treated with anti–vascular endothelial growth factor (anti-VEGF) is optical coherence tomography (OCT), which uses low-coherence interferometry of light to examine the retina in vivo on a micrometer scale.National Institutes of Health (U.S.) (Grant R01-EY11289-25)National Institutes of Health (U.S.) (Grant R01-EY13178-10)National Institutes of Health (U.S.) (Grant R01-EY013516-07)National Institutes of Health (U.S.) (Grant R01-EY019029-02)United States. Air Force Office of Scientific Research (Grant FA9550-10-1-0551)United States. Air Force Office of Scientific Research (Grant FA9550-10-1-0063)Massachusetts Lions Club
Add to ORKG